Conference Coverage

Teleconference is effective in assessing penicillin allergy


 

REPORTING FROM AAAAI/WAO JOINT CONGRESS

Using videoconferencing to assess patients for a reported penicillin allergy saved more than 2 hours of physician time for every patient, and resulted in almost every patient having their allergy label removed, researchers reported.

In what the researchers said was the first study showing the utility of telemedicine in evaluating patient-reported penicillin allergies, allergy and immunology physicians did a secure telemedicine consultation with patients after they underwent penicillin skin testing with a physician assistant; an approach which, on average, took 123 minutes fewer each time than if the physician had done the consultation face-to-face. The teleconference can be done on a laptop or smartphone.

Dr. Allison Ramsey Thomas R. Collins/Frontline Medical Communications

Dr. Allison Ramsey

Of 50 patients prospectively assessed with this approach over a 4-month period last year, 46 (92%) were delabeled, with $23,000 in direct antibiotic cost savings, or $360 per patient, said Allison Ramsey, MD, an allergist at Rochester Regional Health and at the University of Rochester (N.Y). presenting at the joint congress of the American Academy of Allergy, Asthma and Immunology and the World Asthma Organization.

She said the approach is sensible and effective, and it is a good alternative to the traditional way of doing these tests. “What this takes out of that is the travel part. Someone else is doing the travel and the technique of testing,” added that people often are labeled in childhood after getting a rash that was thought to be related to penicillin, but actually was just a coincidence that was unrelated. Then the false allergy label is attached to them for life.

Pages

Recommended Reading

Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis
MDedge Internal Medicine
Ustekinumab quells aortic inflammation in patients with severe psoriasis
MDedge Internal Medicine
VIDEO: Considering systemic disease in dermatology patients
MDedge Internal Medicine
Online psoriasis consultations shown equivalent to office visits
MDedge Internal Medicine
VIDEO: The return of Kaposi’s sarcoma
MDedge Internal Medicine
Phase 3 trials show halobetasol/tazarotene lotion works for psoriasis
MDedge Internal Medicine
Consider drug holidays for BCC patients on hedgehog inhibitors
MDedge Internal Medicine
Study finds AD accounts for hundreds of thousands of annual ED visits
MDedge Internal Medicine
VIDEO: Device-based therapy for onychomycosis
MDedge Internal Medicine
Review finds some evidence of efficacy for nonpharmacological acne therapies
MDedge Internal Medicine